2-氯-n-[4-(6-甲基-1,3-苯并噻唑-2-基)苯基]乙酰胺 | 87992-61-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 中文名称: 2-氯-n-[4-(6-甲基-1,3-苯并噻唑-2-基)苯基]乙酰胺
• 中文别名: 2-氯-N-[4-(6-甲基-1,3-苯并噻唑-2-基)苯基]乙酰胺
• 英文名称: 2-chloro-n-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]acetamide
• CAS: 87992-61-8
• 化学式: C₁₆H₁₃ClN₂OS
• mdl: MFCD00709263
• 分子量: 316.811
• InChiKey: QJGSHPBQTMVTJR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  21
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  70.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2934200090

反应信息

• 作为反应物：
  描述：

  N-(2-吡啶甲基)甘氨酸乙酯 、 2-氯-n-[4-(6-甲基-1,3-苯并噻唑-2-基)苯基]乙酰胺 在 N,N-二异丙基乙胺 作用下， 以 乙腈 为溶剂， 反应 18.0h， 以52%的产率得到
  参考文献：
  名称：

  Evaluation of Re and ^99mTc Complexes of 2-(4′-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals

  摘要：

  The synthesis of M(I)(CO)(3)(NNO) (M = Re, Tc-99m) complexes conjugated to the antitumor agent 2-(4'-aminophenyl)benzothiazole and to its 6-methyl derivative, as well as their in vitro and in vivo biological evaluation as breast cancer radiopharmaceuticals, is reported. The Re complexes displayed under the fluorescence microscope clear uptake by the sensitive to the 2-(4'-aminophenyl)benzothiazole pharmacophore breast cancer cell lines MCF-7 and T47D, while uptake by less sensitive lines and by normal fibroblasts was much weaker. In accordance, uptake of the corresponding radioactive Tc-99m complexes was clearly higher in the breast cancer cell lines MCF-7 and MDA-231 compared to normal fibroblasts. Biodistribution of the Tc-99m complexes in SCID mice bearing MCF-7 xenografts showed appreciable tumor uptake. A tumor/muscle ratio of 2.2 was measured for the complex conjugated to 2-(4'-aminophenyl)benzothiazole that led to successful tumor imaging. The results render the 2-(4'-aminophenyl)benzothiazole complexes potential candidates for imaging (Tc-99m) and targeted radiotherapy (Re-188) of breast cancer.

  DOI：

  10.1021/jm1001293
• 作为产物：
  描述：

  2-(4-氨基苯基)-6-甲基苯并噻唑 、 氯乙酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以75%的产率得到2-氯-n-[4-(6-甲基-1,3-苯并噻唑-2-基)苯基]乙酰胺
  参考文献：
  名称：

  Evaluation of Re and ^99mTc Complexes of 2-(4′-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals

  摘要：

  The synthesis of M(I)(CO)(3)(NNO) (M = Re, Tc-99m) complexes conjugated to the antitumor agent 2-(4'-aminophenyl)benzothiazole and to its 6-methyl derivative, as well as their in vitro and in vivo biological evaluation as breast cancer radiopharmaceuticals, is reported. The Re complexes displayed under the fluorescence microscope clear uptake by the sensitive to the 2-(4'-aminophenyl)benzothiazole pharmacophore breast cancer cell lines MCF-7 and T47D, while uptake by less sensitive lines and by normal fibroblasts was much weaker. In accordance, uptake of the corresponding radioactive Tc-99m complexes was clearly higher in the breast cancer cell lines MCF-7 and MDA-231 compared to normal fibroblasts. Biodistribution of the Tc-99m complexes in SCID mice bearing MCF-7 xenografts showed appreciable tumor uptake. A tumor/muscle ratio of 2.2 was measured for the complex conjugated to 2-(4'-aminophenyl)benzothiazole that led to successful tumor imaging. The results render the 2-(4'-aminophenyl)benzothiazole complexes potential candidates for imaging (Tc-99m) and targeted radiotherapy (Re-188) of breast cancer.

  DOI：

  10.1021/jm1001293

文献信息

• 一种尿不湿用抗菌氨纶纤维及其制备方法
  申请人：诸暨华海氨纶有限公司

  公开号：CN113666886B

  公开（公告）日：2022-03-29

  本发明公开了一种尿不湿用抗菌氨纶纤维及其制备方法，涉及化学纤维材料技术领域。该抗菌氨纶纤维的制备方法，包括：采用连续聚合生产工艺，取PTG、MDI进行预聚合反应合成异氰酸酯端基的预聚物；向上述预聚物中加入扩链剂扩链得到聚氨酯原液；取上述聚氨酯原液与抗菌剂、功能助剂共混，并经熟化后得到纺丝液，干法纺丝、假捻、上油、卷绕即得抗菌氨纶纤维。本发明制得的氨纶纤维具有更佳的力学性能和弹性回复性能，且抗菌效果优异，具有良好的除臭作用；同时其抗蠕变性能更强，显著提升氨纶通过胶水与无纺布的粘合牢固性。
• MOHARRAM, H. H.;EL, BAYOUKI, KH. A.;MANSOUR, S. A., EGYPT. J. CHEM., 1984, 27, N 2, 241-245
  作者：MOHARRAM, H. H.、EL, BAYOUKI, KH. A.、MANSOUR, S. A.

  DOI：——

  日期：——
• Evaluation of Re and ^99mTc Complexes of 2-(4′-Aminophenyl)benzothiazole as Potential Breast Cancer Radiopharmaceuticals
  作者：Stamatia Tzanopoulou、Marina Sagnou、Maria Paravatou-Petsotas、Eleni Gourni、George Loudos、Stavros Xanthopoulos、Daniel Lafkas、Hippokratis Kiaris、Alexandra Varvarigou、Ioannis C. Pirmettis、Minas Papadopoulos、Maria Pelecanou

  DOI：10.1021/jm1001293

  日期：2010.6.24

  The synthesis of M(I)(CO)(3)(NNO) (M = Re, Tc-99m) complexes conjugated to the antitumor agent 2-(4'-aminophenyl)benzothiazole and to its 6-methyl derivative, as well as their in vitro and in vivo biological evaluation as breast cancer radiopharmaceuticals, is reported. The Re complexes displayed under the fluorescence microscope clear uptake by the sensitive to the 2-(4'-aminophenyl)benzothiazole pharmacophore breast cancer cell lines MCF-7 and T47D, while uptake by less sensitive lines and by normal fibroblasts was much weaker. In accordance, uptake of the corresponding radioactive Tc-99m complexes was clearly higher in the breast cancer cell lines MCF-7 and MDA-231 compared to normal fibroblasts. Biodistribution of the Tc-99m complexes in SCID mice bearing MCF-7 xenografts showed appreciable tumor uptake. A tumor/muscle ratio of 2.2 was measured for the complex conjugated to 2-(4'-aminophenyl)benzothiazole that led to successful tumor imaging. The results render the 2-(4'-aminophenyl)benzothiazole complexes potential candidates for imaging (Tc-99m) and targeted radiotherapy (Re-188) of breast cancer.